{'fraction_non_alphanumeric': 0.04552129221732746, 'fraction_numerical': 0.020558002936857563, 'mean_word_length': 4.982456140350878, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI

To improve multiple sclerosis (MS) research by introducing a new type of contrast, namely, the combination of fluid‐attenuated inversion recovery (FLAIR) data acquired at 3.0 T and 7.0 T susceptibility‐weighted imaging (SWI) phase data. The approach of this new contrast is whole‐brain coverage with 3.0 T‐FLAIR data for lesion detection—currently limited at 7.0 T due to specific absorption rate (SAR) limits—overlaid with high‐resolution, small vessel, and iron‐related 7.0 T SWI contrast. Lesion analysis in terms of penetrating veins and local iron depositions were performed.